Fat Loss Weight Loss 

Weight Loss Shredder – Lose weight fast 10 pounds in one week

Product Name: Weight Loss Shredder – Lose weight fast 10 pounds in one week Click here to get Weight Loss Shredder – Lose weight fast 10 pounds in one week at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Weight Loss Shredder – Lose weight fast 10 pounds in one week is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not…

Read More
Fat Loss 

3-Site Body Composition Calculator: This free online calculator will help you to…

3-Site Body Composition Calculator: This free online calculator will help you to calculate your body fat percentage when using a skin fold caliper. The body fat calculations are based on the Jackson/Pollock 3-Site Caliper Method. The calculator page includes images showing the three measurement sites for both males and females. Source by calcwinder

Read More
Fat Loss 

Stockbyte/Stockbyte/Getty Images…

Stockbyte/Stockbyte/Getty Images Source by gabriellaferri

Read More
Weight Loss 

6MinutesToSkinny…. | This Is What Happens When You Dont Do Squats Pictures, Ph…

6MinutesToSkinny…. | This Is What Happens When You Dont Do Squats Pictures, Photos, and Images for Facebook, Tumblr, Pinterest, and Twitter workout, #before and after Source by janpak3r

Read More
Weight Loss 

Fitness Male Fitness Model Motivation Model Workout Tumblr Before And After Diet Competition Quotes Back Body Photos Images Wallpapers

Male Fitness Model Motivation Model Workout Tumblr Before and After Diet Competition Quotes Back: Fitness Male Fitness Model Motivation Model Workout Tumblr Before And After Diet Competition Quotes Back Body Photos Images Wallpapers Source by tarantino88

Read More

FDA Approves Implant to Battle Opioid Addiction

www.judgeweightloss.com/bikinibutt

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

THURSDAY, May 26, 2016 (HealthDay News) — A new long-acting implant that can help treat people addicted to heroin and prescription painkillers was approved Thursday by the U.S. Food and Drug Administration.

“Opioid abuse and addiction have taken a devastating toll on American families. We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives,” FDA Commissioner Dr. Robert M. Califf said in a statement. “Today’s approval provides the first-ever implantable option to support patients’ efforts to maintain treatment as part of their overall recovery program.”

Probuphine is placed in the upper arm of recovering addicts and releases a steady six-month dose of buprenorphine, an anti-addiction drug designed to combat the cravings that come with opioids like heroin or powerful prescription painkillers like Percocet or OxyContin. Buprenorphine is already available as a pill or a film that can be placed in the mouth.

The steady flow from the implant will reduce fluctuations that can occur when taking a medication once or twice daily, and it removes the need for a patient to remember to take it, said Dr. Annie Umbricht, an expert in substance abuse treatment at Johns Hopkins University in Baltimore.

“A person suffering from addiction would not have to go through the up-and-downs of a daily medication, and therefore will feel much more normal,” Umbricht explained.

Clinical trials published in the Journal of the American Medical Association in 2010 showed the implant led to higher abstinence rates among addicts, with 40 percent remaining drug-free compared with 28 percent receiving a placebo.

People given the implant also were more likely to remain in treatment, about 66 percent compared with 31 percent of the placebo group.

“It really reduces or eliminates cravings, and they don’t start searching around for opiates,” said Dr. Scott Segal, president and chief medical officer of the Segal Institute for Clinical Research in Miami, one of the centers that participated in the clinical trials.

The implant provides patients with no-fail treatment during its six-month period of effectiveness, Segal said.

“Things happen in life,” he said. “You miss your doctor’s appointment, the pharmacy doesn’t have the medication and there’s problems. The implant takes relapse off the table.”

It takes about 15 minutes to place the implant, Segal said, and side effects are similar to oral buprenorphine. They include headache, depression, constipation, nausea, vomiting and back pain, according to the FDA.

“I was concerned that patients would [not] like this option, and I was dead wrong,” he said. “The patients enrolled quickly. They liked it. They tolerated it well. And they were upset when we took them off the implant at the end of the study.”

The United States is experiencing an epidemic of prescription drug abuse, and the new implant could also help counter that, Umbricht said.

There were 28,647 overdose deaths related to heroin and prescription pain killers in 2014, an average of 78 per day, according to the U.S. Centers for Disease Control and Prevention.

That’s because people undergo treatment and lose their tolerance for opioids, but then leave treatment with a high risk of relapse, Umbricht said.

“We know the rate of relapse after drug treatment is more than 90 percent,” Umbricht said. “These people have lost their tolerance, but they don’t realize it. They are at high risk for overdose.”

The implant can help stabilize addicts during treatment, and then provide them with support against relapse once they’ve been released, she said.

Buprenorphine provides effects that are similar to, but weaker than, opioids like heroin or methadone, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

But those effects level off at moderate doses, lowering the risk of misuse and addiction, SAMHSA says.

Buprenorphine also interferes with the effects of full-strength opiates, Segal said.

“It tends to saturate the receptors that respond to opiates,” he said. “Even if you were to take opiates with it, you won’t get high. It provides pain relief, but doesn’t give them the buzz or high that heroin would.”

The implant eliminates one other concern associated with oral buprenorphine—the likelihood that someone with a prescription will share their pills with friends.

Researchers estimate that as much as 50 percent of oral buprenorphine prescriptions are “diverted,” Umbricht said.

The intent is most likely to help other people quit their drug habit, Umbricht said, but without drug counseling those addicts are not likely to succeed.

“That person is not going to get the psychosocial support they need,” Umbricht said, adding that drug sharing also maintains illegal behaviors that recovering addicts need to shake.

Addiction specialist Dr. Kevin Cotterell agreed.

“The prospect of a long-acting opiate agonist-antagonist surgically implanted for use in the treatment of addiction to opiates is very encouraging,” said Cotterell, a psychiatrist with South Oaks Hospital in Amityville, N.Y. “It will help in overcoming problems with compliance, which is a great barrier to recovery. It will enhance safety and reduce diversion if used widely.”

More information

For more on buprenophine, visit the Substance Abuse and Mental Health Services Administration.


Also check out healthywithjodi.com

Read More

At Least 10 Pregnant Women in Dallas Have Zika Virus, Officials Say

www.judgeweightloss.com

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

THURSDAY, June 23, 2016 (HealthDay News) — At least 10 pregnant women in the Dallas area have been infected with Zika, Texas officials confirmed Wednesday.

All of the women contracted the mosquito-borne virus while traveling abroad, Dallas Health and Human Services officials told CBS News.

In related news, the U.S. House on Thursday approved a $1.1 billion funding package to combat the Zika threat, the Associated Press reported.

The bill still needs to be approved by the U.S. Senate, and it remains to be seen if President Barack Obama will sign it. Obama originally asked Congress for $1.9 billion, and Democrats and the White House have voiced opposition to certain provisions of the package.

Even though there have been no local transmissions of Zika reported yet in the United States, the number of cases of infection among pregnant women keeps climbing.

As of June 9, the U.S. Centers for Disease Control and Prevention reported there are 234 cases of pregnant women on the U.S. mainland who have been infected with Zika, which typically involves relatively mild symptoms in most adults. However, it can cause devastating birth defects in babies that include microcephaly, where an infant is born with an abnormally small head and brain.

In Latin America, thousands of babies have already been born with microcephaly. And researchers reported Wednesday that fears over Zika-related birth defects may be driving up abortion rates in Latin American countries affected by the virus.

In Brazil and Ecuador—where governments have issued health warnings on the danger to the fetus from maternal Zika infection—requests for abortion in 2016 have doubled from 2010 rates, the researchers reported.

The other 17 Latin American countries covered by the new study had their rates rise by more than a third during that time, according to the report in the New England Journal of Medicine.

The researchers noted that because data on family planning in Latin America is often hard to come by, their numbers may underestimate the surge in abortions since Zika’s emergence.

“The World Health Organization predicts as many as 4 million Zika cases across the Americas over the next year, and the virus will inevitably spread to other countries,” noted study senior author Dr. Catherine Aiken, of the University of Cambridge in England.

But no nation has been more affected than Brazil. As a result of the Zika epidemic, almost 5,000 babies have been born with microcephaly there.

However, the CDC warned last Friday that infection rates are rising in Puerto Rico. Testing of blood donations in the U.S. territory—”our most accurate real-time leading indicator of Zika activity”—suggest that more and more people on the island have been infected, according to CDC Director Dr. Tom Frieden.

“The real importance of this information is that in coming months it’s possible that thousands of pregnant women in Puerto Rico could become infected with Zika,” Frieden stressed. “This could lead to dozens or hundreds of infants being born with microcephaly in the coming year,” he added.

“Controlling this mosquito is very difficult,” Frieden said. “It takes an entire community working together to protect a pregnant woman.”

Because the virus remains largely undetected, it will be months before affected babies begin to be born, Frieden said. Some will have microcephaly or other brain-related birth defects. But many will appear healthy and normal, and there’s no way to know how they might have been affected, he explained.

Zika is typically transmitted via the bite of the Aedes aegypti mosquito. But, transmission of the virus through sex is more common than previously thought, World Health Organization officials have said.

Women of child-bearing age who live in an active Zika region should protect themselves from mosquitoes by wearing long-sleeved shirts and long pants, using mosquito repellent when outside, and staying indoors as much as possible, according to the CDC.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on the Zika virus.

This Q&A will tell you what you need to know about Zika.

To see the CDC list of sites where Zika virus is active and may pose a threat to pregnant women, click here.


Also check out healthywithjodi.com

Read More

FDA Approves Implant to Battle Opioid Addiction

www.judgeweightloss.com

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Dennis Thompson
HealthDay Reporter

THURSDAY, May 26, 2016 (HealthDay News) — A new long-acting implant that can help treat people addicted to heroin and prescription painkillers was approved Thursday by the U.S. Food and Drug Administration.

“Opioid abuse and addiction have taken a devastating toll on American families. We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives,” FDA Commissioner Dr. Robert M. Califf said in a statement. “Today’s approval provides the first-ever implantable option to support patients’ efforts to maintain treatment as part of their overall recovery program.”

Probuphine is placed in the upper arm of recovering addicts and releases a steady six-month dose of buprenorphine, an anti-addiction drug designed to combat the cravings that come with opioids like heroin or powerful prescription painkillers like Percocet or OxyContin. Buprenorphine is already available as a pill or a film that can be placed in the mouth.

The steady flow from the implant will reduce fluctuations that can occur when taking a medication once or twice daily, and it removes the need for a patient to remember to take it, said Dr. Annie Umbricht, an expert in substance abuse treatment at Johns Hopkins University in Baltimore.

“A person suffering from addiction would not have to go through the up-and-downs of a daily medication, and therefore will feel much more normal,” Umbricht explained.

Clinical trials published in the Journal of the American Medical Association in 2010 showed the implant led to higher abstinence rates among addicts, with 40 percent remaining drug-free compared with 28 percent receiving a placebo.

People given the implant also were more likely to remain in treatment, about 66 percent compared with 31 percent of the placebo group.

“It really reduces or eliminates cravings, and they don’t start searching around for opiates,” said Dr. Scott Segal, president and chief medical officer of the Segal Institute for Clinical Research in Miami, one of the centers that participated in the clinical trials.

The implant provides patients with no-fail treatment during its six-month period of effectiveness, Segal said.

“Things happen in life,” he said. “You miss your doctor’s appointment, the pharmacy doesn’t have the medication and there’s problems. The implant takes relapse off the table.”

It takes about 15 minutes to place the implant, Segal said, and side effects are similar to oral buprenorphine. They include headache, depression, constipation, nausea, vomiting and back pain, according to the FDA.

“I was concerned that patients would [not] like this option, and I was dead wrong,” he said. “The patients enrolled quickly. They liked it. They tolerated it well. And they were upset when we took them off the implant at the end of the study.”

The United States is experiencing an epidemic of prescription drug abuse, and the new implant could also help counter that, Umbricht said.

There were 28,647 overdose deaths related to heroin and prescription pain killers in 2014, an average of 78 per day, according to the U.S. Centers for Disease Control and Prevention.

That’s because people undergo treatment and lose their tolerance for opioids, but then leave treatment with a high risk of relapse, Umbricht said.

“We know the rate of relapse after drug treatment is more than 90 percent,” Umbricht said. “These people have lost their tolerance, but they don’t realize it. They are at high risk for overdose.”

The implant can help stabilize addicts during treatment, and then provide them with support against relapse once they’ve been released, she said.

Buprenorphine provides effects that are similar to, but weaker than, opioids like heroin or methadone, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).

But those effects level off at moderate doses, lowering the risk of misuse and addiction, SAMHSA says.

Buprenorphine also interferes with the effects of full-strength opiates, Segal said.

“It tends to saturate the receptors that respond to opiates,” he said. “Even if you were to take opiates with it, you won’t get high. It provides pain relief, but doesn’t give them the buzz or high that heroin would.”

The implant eliminates one other concern associated with oral buprenorphine—the likelihood that someone with a prescription will share their pills with friends.

Researchers estimate that as much as 50 percent of oral buprenorphine prescriptions are “diverted,” Umbricht said.

The intent is most likely to help other people quit their drug habit, Umbricht said, but without drug counseling those addicts are not likely to succeed.

“That person is not going to get the psychosocial support they need,” Umbricht said, adding that drug sharing also maintains illegal behaviors that recovering addicts need to shake.

Addiction specialist Dr. Kevin Cotterell agreed.

“The prospect of a long-acting opiate agonist-antagonist surgically implanted for use in the treatment of addiction to opiates is very encouraging,” said Cotterell, a psychiatrist with South Oaks Hospital in Amityville, N.Y. “It will help in overcoming problems with compliance, which is a great barrier to recovery. It will enhance safety and reduce diversion if used widely.”

More information

For more on buprenophine, visit the Substance Abuse and Mental Health Services Administration.


Also check out healthywithjodi.com

Read More

Sugary Drinks and 'Bad' Carbs May Increase Risk of These Types of Cancer

www.judgeweightloss.com/sixpackabs

The place to come for fitness, weight loss, supplement, and just awesome health info.

Thanks for visiting. Enjoy

By Amy Norton
HealthDay Reporter

TUESDAY, April 5, 2016 (HealthDay News) — People who consume a lot of processed carbohydrates—think snack foods and sweets—and sugary drinks may face heightened risks of breast and prostate cancers, a new study suggests.

Researchers said the study, reported Tuesday at the American Society for Nutrition annual meeting in San Diego, does not prove that “bad” carbs cause cancer.

But given that breast and prostate cancers are two of the most common cancers in the United States, the connection gives more reason for people to cut processed foods from their diets, said lead researcher Nour Makarem.

“The carbohydrate quality of your diet matters for a number of reasons,” said Makarem, a Ph.D. candidate in nutrition at New York University.

In general, health experts already recommend limiting sugary drinks and processed carbohydrates, and eating more fruits, vegetables, legumes, fiber-rich whole grains, and “good” unsaturated fats.

So the new findings—considered preliminary until published in a peer-reviewed medical journal—add more weight to that advice, Makarem said.

She pointed, in particular, to the link her team found between sugar-sweetened drinks (both soda and fruit juice) and prostate cancer risk. Compared with men who never drank sugary beverages, those who had them a few times a week showed more than triple the risk of developing prostate cancer.

And that was with other factors—including obesity, smoking, and other diet habits—taken into account, Makarem said.

Still, it is difficult to weed out the effects of particular diet habits on cancer risk, said Marji McCullough, strategic director of nutritional epidemiology for the American Cancer Society.

“Few dietary factors apart from alcohol and/or obesity have been consistently related to postmenopausal breast cancer and prostate cancer,” McCullough said.

The question of whether carbohydrate quality affects cancer risk—independent of obesity—is important, according to McCullough. But it’s also a “challenging” one to answer, she said.

The new findings are based on nearly 3,200 U.S. adults whose diet habits and cancer rates were tracked for more than 20 years. During that time, 565 people were diagnosed with cancer.

At first glance, higher carb intake was tied to a lower risk of breast cancer. But the picture changed when carb quality was considered, Makarem noted.

She said that women whose diets emphasized healthy carbs—vegetables, fruit, whole grains, and legumes—were 67 percent less likely to develop breast cancer, compared to women who favored refined carbs. Refined carbs include many baked goods, white bread and white potatoes.

When it came to prostate cancer risk, men who regularly drank sugary juices or soda were more than three times as likely to develop disease versus men who steered clear of those drinks, the findings showed.

That does not prove sweet drinks directly contribute to prostate cancer, Makarem acknowledged. Still, she said, many studies have implicated the beverages in the risks of obesity and type 2 diabetes—so there are other reasons to cut back.

“Plus,” Makarem said, “it’s an easy change to make in your diet.”

The American Beverage Association took issue with the findings.

“The authors of this study abstract acknowledge their findings do not show that beverages cause any disease,” the group said in a statement. “Moreover, the study was limited to one demographic group that is not reflective of the population of the United States.” (Most study participants were white.)

The beverage association also said that the American Cancer Society cites multiple potential risk factors for breast, prostate and colon cancer, so singling out diet is difficult. The group also said that because the study hasn’t been published in a peer-reviewed journal, “very few study details are available” and it’s therefore tough to draw firm conclusions.

Sugary drinks weren’t the only diet factor that mattered, though, according to the researchers. Prostate cancer risk was also heightened among men whose diets were generally high in “glycemic load”—which, Makarem said, basically means they ate a lot of refined carbs.

The study also implicated “processed lunch foods,” including pizza, deli meats, and burgers. Men who ate those foods four or more times a week were twice as likely to develop prostate cancer, compared to men who had them no more than once a week, the researchers found.

According to McCullough, it’s hard to know whether certain foods, per se, contribute to breast or prostate cancers—or whether, for example, it’s overall calorie intake and weight gain that are the true culprits.

But the bottom line, Makarem said, is that whole, “high-quality” foods are a generally healthier choice than processed ones.

More information

The American Cancer Society has more on diet and cancer risk.


Also check out healthywithjodi.com

Read More